After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. | After Novartis and Roche grew their sales last year, the ...

CeriBell's AI-powered EEG system offers rapid seizure diagnosis. The stock is undervalued by at least 50% over the long-term, ...

Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...

Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...

As HR's strategic role evolves, people professionals must leverage tech alongside human skills to drive success, says BVI ...

What’s the full story? Seaport lays out a bullish case, starting with the massive total addressable market for groceries, ...

This led to some of the major pharma companies setting up shop in the country, such as Novartis, GSK ... As the industry grew, a vibrant talent base and extraordinary levels of compliance with ...

Hello there. I don’t know if Mitsotakis got off easy back in 2018 with the rolling suitcases of the Novartis scandal—"the scandal of the century," as Mimi ...

Novartis exceeds Q4 2024 expectations with 16% sales growth, strong EPS trajectory, and strategic R&D investments. Read why ...

Novartis: 1996 – 2013 Dr Daniel Vasella was the first CEO of the newly merged company. Vasella was hired by Sandoz back in 1988 and remained there until 1992 when he was promoted to CEO of its ...

Eye Health Ingredients Market BURLINGAME, CA, UNITED STATES, February 21, 2025 /EINPresswire / -- The latest study, titled Eye Health Ingredie ...

In early January came news that Marquee Brands, which is backed by Neuberger Berman , acquired Laura Ashley, the iconic London-based brand that sells home furnishings and fashion items. The seller was ...